JPMorgan To Provide Financial Advisory Services To Marshall Edwards

JPMorgan will act as financial advisor with respect to Marshall Edwards' strategic alternatives relating to phenoxodiol, and advisor for company business transactions. "Marshall Edwards is very pleased to have the international and strategic experience of the JPMorgan team involved in

By None

JPMorgan will act as financial advisor with respect to Marshall Edwards’ strategic alternatives relating to phenoxodiol, and advisor for company business transactions.

“Marshall Edwards is very pleased to have the international and strategic experience of the JPMorgan team involved in the company’s corporate development,” says Christopher Naughtn, the CEO and President of Marshall Edwards, Inc. “The company’s strategic alternatives for the anti- cancer drug phenoxodiol which is now entering phase III clinical trials is the first of the projects upon which JPMorgan will be offering advice and coordination assistance.”

«